Eagle Pharmaceuticals logo
Eagle Pharmaceuticals EGRX
$ 3.95 -2.71%

Quarterly report 2023-Q2
added 08-08-2023

report update icon

Eagle Pharmaceuticals Long Term Debt Current 2011-2024 | EGRX

Annual Long Term Debt Current Eagle Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.53 M 1.31 M 1.12 M 5 M 6.25 M 4.88 M - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.25 M 1.12 M 3.35 M